BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
13 results:

  • 1. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
    Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; O'Donnell PH; Kalebasty AR; Ye D; Mariathasan S; Bene-Tchaleu F; Bernhard S; Lee C; Davis ID; Galsky MD
    Lancet Oncol; 2024 Jan; 25(1):29-45. PubMed ID: 38101433
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
    Shen Q; Liu YX; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
    Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
    Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Robot-assisted partial nephrectomy for high-complexity tumors (PADUA score ≥10): Perioperative, long-term functional and oncologic outcomes.
    Koukourikis P; Alqahtani AA; Almujalhem A; Lee J; Han WK; Rha KH
    Int J Urol; 2021 May; 28(5):554-559. PubMed ID: 33604916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.
    Zeng Y; Zhang W; Li Z; Zheng Y; Wang Y; Chen G; Qiu L; Ke K; Su X; Cai Z; Liu J; Liu X
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439798
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [
    Hall LT; Titz B; Baidya N; van der Kolk AG; Robins HI; Otto M; Perlman SB; Weichert JP; Kuo JS
    Mol Imaging Biol; 2020 Apr; 22(2):434-443. PubMed ID: 31183841
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Robot-assisted Partial Nephrectomy for Complex (PADUA Score ≥10) tumors: Techniques and Results from a Multicenter Experience at Four High-volume Centers.
    Buffi NM; Saita A; Lughezzani G; Porter J; Dell'Oglio P; Amparore D; Fiori C; Denaeyer G; Porpiglia F; Mottrie A;
    Eur Urol; 2020 Jan; 77(1):95-100. PubMed ID: 30898407
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan.
    Lien YC; Wang JY; Lee MC; Shu CC; Chen HY; Hsieh CH; Lee CH; Lee LN; Chao KM
    Br J Cancer; 2013 Nov; 109(11):2933-40. PubMed ID: 24129236
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials.
    Lambrechts D; Claes B; Delmar P; Reumers J; Mazzone M; Yesilyurt BT; Devlieger R; Verslype C; Tejpar S; Wildiers H; de Haas S; Carmeliet P; Scherer SJ; Van Cutsem E
    Lancet Oncol; 2012 Jul; 13(7):724-33. PubMed ID: 22608783
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy.
    Maes P; Delemarre J; de Kraker J; Ninane J
    Eur J Cancer; 1999 Sep; 35(9):1356-60. PubMed ID: 10658527
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy.
    Verheij M; Dewit LG; Valdés Olmos RA; Arisz L
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):677-83. PubMed ID: 7928500
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. renal tumors and tumor-like lesions in pediatric patients.
    Kissane JM; Dehner LP
    Pediatr Nephrol; 1992 Jul; 6(4):365-82. PubMed ID: 1323320
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin.
    Belinson JL; McClure M; Ashikaga T; Krakoff IH
    Cancer; 1984 Nov; 54(9):1983-90. PubMed ID: 6548172
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.